Ophir Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Ophir Asset Management's CDNA Position: Q2 2026 in Review
Ophir Asset Management increased its CareDx (CDNA) stake by 28% in Q2 2026, buying an estimated $6.02M and bringing the position to 1,264,809 shares worth $36M. The position accounts for 2.96% of the portfolio, ranked #15.
Ophir Asset Management first reported a position in CDNA in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Ophir Asset Management held 1,264,809 shares of CareDx worth $36M as of Q2 2026.
- Ophir Asset Management bought 276,758 CareDx shares in Q2 2026, an estimated $6.02M.
- CareDx made up 2.96% of Ophir Asset Management's portfolio in Q2 2026, its #15 holding.
- Ophir Asset Management first reported a position in CareDx in Q1 2025 and has held it in 6 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Ophir Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.